ArticleBMC nephrology2025
Delayed graft function as a predictor of chronic allograft dysfunction: a 10-year follow-up study.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recipient-driven and donor-driven determinants of delayed graft function in paired kidney transplantation: evidence from a Chinese cohort.Renal failure · 2026Article
- Clinical Benefit and Remaining Risks of Kidney Transplantation in Older Patients: A Matched Comparison With CKD Patients.Journal of the American Geriatrics Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delayed graft function (DGF) is a common complication following kidney transplantation, yet its long-term implications for chronic allograft dysfunction (CAD) remain incompletely understood. This retrospective cohort study analyzed data from 3,850 kidney transplant recipients (KTRs)registered in the China Kidney Transplant Registry (CKTR, 2014–2024) to explore the association between DGF and CAD. DGF was defined as the requirement for dialysis within the first 7 days post-transplantation, while CAD was diagnosed based on either biopsy-confirmed interstitial fibrosis/tubular atrophy or a sustained decline in estimated glomerular filtration rate (eGFR) to < 30 mL/min/1.73 m2. Over a median follow-up of 10.2 years (calculated from the 1-year post-transplant landmark), 17.7% of recipients developed DGF, and 32.3% were diagnosed with CAD. Notably, the incidence of CAD was significantly higher in patients with DGF compared to those without (42.5% vs. 29.1%, P < 0.001). Multivariate analysis confirmed DGF as an independent predictor of CAD (adjusted hazard ratio [aHR] = 1.48, 95% CI: 1.25–1.75, P < 0.001). Stratified analyses further revealed stronger associations in high-risk subgroups, including recipients of extended-criteria donor (ECD) kidneys (aHR = 1.72, P = 0.003) and those receiving calcineurin inhibitor (CNI)-free immunosuppressive regimens (aHR = 1.65, P = 0.001). These findings identify DGF as a potential risk factor for CAD, with exploratory evidence of particularly pronounced effects in specific vulnerable populations. This underscores the need for enhanced long-term monitoring and personalized interventions in high-risk patients to optimize graft survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.